Osmundsen H., Bremer J., Pedersen J. I. Metabolic aspects of peroxisomal betaoxidation. Biochim Biophys Acta. 1991 Sep 11; 1085(2):141–58. doi:10.1016/0005-2760(91)90089-Z.
Pande S. V. A mitochondrial carnitine acylcarnitine translocase system. Proc Natl Acad Sci U S A. 1975 Mar; 72(3):883–7.
Pande S. V., Parvin R. Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well. J Biol Chem. 1980 Apr 10; 255(7):2994–3001.
Plioplys A. V., Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995; 32:132–8.
Pons R., De Vivo D. C. Primary and secondary carnitine deficiency syndromes. J Child Neurol. 1995 Nov 1; 10 Suppl 2:S8–24.
Ramsay R. R., Arduini A. The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys. 1993 May; 302(2):307–14. doi:10.1006/abbi.1993.1216.
Rebouche C. J. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann NY Acad Sci. 2004 Nov;1033:30–41. Rebouche C. J., Paulson D. J. Carnitine metabolism and function in humans. Annu Rev Nutr. 1986; 6:41–66.
Rebouche C. J., Paulson D. J. Carnitine function and requirements during the life cycle. FASEB J. 1992; 6 (15):3379–86. doi:10.1146/annurev. nu.06.070186.000353.
Reuter S. E., Evans A. M. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet. 2012 Sep 1; 51(9):553–72. doi:10.2165/11633940-000000000-00000.
Sachan D. S., Broquist H. P. Synthesis of carnitine from epsilon-N-trimethyllysine in post mitochondrial fractions of Neurospora crassa. Biochem Biophys Res Commun. 1980 Sep 30; 96(2):870–5. doi:10.1016/0006-291X(80)91436-9.
Sachan D. S., Hoppel C. L. Carnitine biosynthesis. Hydroxylation of N-6-trimethyl-lysine to 3-hydroxy-N6-trimethyl-lysine. Biochem J. 1980 May 15; 188 (2):529–34. doi:10.1042/bj1880529.
Serati A. R., et al. L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms. Cardiology. 2010; 116(3):178–82. doi:10.1159/000318810.
Sinatra S. T. The Sinatra solution: metabolic cardiology. Laguna Beach, CA: Basic Health Publications, Inc; 2011.
Steiber A., Kerner J., Hoppel C. L. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med. 2004 Oct — Dec; 25(5–6):455–73. doi:10.1016/j.mam.2004.06.006.
Tanphaichitr V., Broquist H. P. Role of lysine and e — N-trimethyllysine in carnitine biosynthesis. II: studies in the rat. J Biol Chem. 1973; 248(6):2176–81.
Vaz F. M., Wanders R. J. Carnitine biosynthesis in mammals. Biochem J. 2002 Feb 1; 361(Part 3): 417–29. doi:10.1042/bj3610417.
Virmani A., et al. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann NY Acad Sci. 2002 Jun;965:225–32. doi:10.1111/j.1749–6632.2002.tb04164.
Магний
Abbott R. D., et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol. 2003 Sep 15; 92(6):665–9. doi:10.1016/S0002 -9149(03)00819-1.
Alloui A., et al. Does Mg2+ deficiency induce a long-term sensitization of the central nociceptive pathways? Eur J Pharmacol. 2003 May 23; 469(l–3)65–9. doi:10.1016/S0014-2999 (03)01719-9.
Amighi J., et al. Low serum magnesium predicts neurological patients with advanced atherosclerosis. Stroke. 2004 Jan;35(1):22–7. doi:10.1161/01. STR.0000105928.95124.1F.
Demougeot C., et al. Effect of diets with different magnesium content in ischemic stroke rats. Neurosci Lett. 2004 May 13;362(1):17–20. doi:10.1016/j.neulet.2004.01.034.
Eray O., et al. Magnesium efifcacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation. Eur J Emerg Med. 2000 Dec; 7(4):287–90.
Fox C., Ramsoomair D., Carter C. Magnesium: its proven and potential clinical significance. South Med J. 2001 Dec; 94(12):1195–201.
Hagen T. M., et al. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 1999 Feb; 13(2):411–8.
Hagen T. M., et al. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann NY Acad Sci. 2002 Apr; 959:491–507. doi:10.1111/j.1749–6632.2002.tb02119.
Hans C. P., Chaudhary D. P., Bansal D. D. Magnesium deficiency increases oxidative stress in rats. Ind J Exp Biol. 2002 Nov; 40(11):1275–9.
Hans C. P., Chaudhary D. P., Bansal D. D. Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res. 2003 Mar; l6(1):13–9.
Klevay L. M., Milne D. B. Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr. 2002 Mar; 75(3):550–4.
Kramer J. H., et al. Dietary magnesium intake influences circulating proinflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med (Maywood). 2003 Jun; 228(6):665–73. Kubota T., et al. Mitochondria are intracellular magnesium stores: investigation by simultaneous fluorescent imagings in PC12 cells. Biochim Biophys Acta. 2005 May 15; 1744(1):19–28. Epub 2004 Nov 11. doi:10.1016/j. bbamcr.2004.10.013.
Laires M. J., Monteiro C. P., Bicho M. Role of cellular magnesium in health and human disease. Front Biosci. 2004 Jan; 9:262–76.
Lukaski H. C., Nielsen F. H. Dietary magnesium depletion affects metabolic responses during submaximal exercise in postmenopausal women. J Nutr. 2002 May; 132(5):930–5.
Maier J. A., et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta. 2004 May 24; 1689(l):13–21. doi:10.1016/j.bba-dis.2004.01.002.
Moreira P. I., et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis. 2007 Sep; 12(2):195–206.
Nair R. R., Nair P. Alteration of myocardial mechanics in marginal magnesium deficiency. Magnes Res. 2002 Dec; 15(3–4):287–306.
Nakayama S., et al. Mechanisms for monovalent cation-dependent depletion of intracellular Mg2+:Na(+)-independent Mg2+ pathways in guinea-pig smooth muscle. J Physiol. 2003 Sep 15;551(Pt 3):843–53. doi:10.1113/ jphysiol.2003.047795.
Paolisso G., Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hyperten. 1997 Mar 1;10(3):346–55. doi:10.1016/S0895 -7061(96)00342-1.
